Charles River Laboratories, Inc. vs Seikagaku Corporation

Petitioner's Opposition to Patent Owner's Motion to Compel Routine Discovery

Email from S. McKeown RE: PGR2025-00023 and IPR2025-00440: Request for Position on Motions to Compel Routine Discovery (Jun. 25, 2025)

Patent Owner's Motion to Compel Routine Discovery

Transcript of August 1, 2025 Conference Call

Notice of Filing Transcript of August 1, 2025 Conference Call

Ex. 3002 Attorney Correspondence

Order: Authorizing Discovery

Director Discretionary Decision: Refer

Ex. 3101

Patent Owner's Preliminary Response

U.S. Patent Application Publication No. 20030054432A1

Alwis and Milton, Am. J. Indus. Med. 49 296-300 (2006)

Mustopa, et al., J. Genetic Eng’g and Biotechnology, 21 44 (2023)

Certified English Translation of WO2008004674A1

U.S. Pharmacopoeia, Ch. 85

European Pharmacopoeia 5.0

Japanese Pharmacopoeia-XV

Dubczak, Charles River Laboratories PDA Letter (2018)

U.S. Patent Application Publication No. 20090208995

U.S. Patent No. 9,040,254

Iwanaga, Proc. Jpn. Acad., Ser. B 83 110-119 (2007)

Kawabata, et al., Invertebrate Survival J. 6(1) 59-77 (2009)

Iwanaga and Lee, J. Biochem. and Mol. Biol. 38(2)128-150 (2005)

D’Amato, et al., J. Proteome Rsch. 9 3260-3269 (2010)

U.S. Appln. No.: 17/554,128, Non-Final Office Action, Mar. 20, 2025 ("'128 App. NFR")

European Patent No. 3530670, Response to Opposition, May 9, 2025

European Patent No. 3441466, Decision on Opposition, Oct. 26, 2022

USP, General Chapter Prospectus: Use of Recombinant Reagents in Bacterial Endotoxins Test

Interim Processes for PTAB Workload Management Memo

U.S. Appln. No.: 17/554,128, Amendment, Jan. 28, 2025

European Patent No. 3530670, Notice of Opposition, Nov. 22, 2024

U.S. Appln. No.: 16/331,810, Notice of Abandonment, Mar. 14, 2023

USP Press Release

U.S. Appln. No.: 14/650,767, Non-Final Office Action, Sept. 16, 2016

U.S. Appln. No.: 18/346,420, Non-Final Office Action, Sept. 15, 2023

Law360 Article

U.S. Appln. No.: 14/650,767, Preliminary Amendment, Jun. 9, 2015

U.S. Patent No. 10,144,923

U.S. Patent No. 10,982,202

U.S. Patent No. 6,391,570

Petitioner's Opposition to Patent Owner's Discretionary Denial Brief

Patent Owner's Discretionary Denial Brief

Disclaimer of Claim 10 in U.S. Patent No. 11,959,109

Muta et al., J. Biol Chem. 268(28) 21384-88 (1993)

Muta et al., J. Biol Chem. 265(36) 22426-33 (1990)

Declaration of Michael Frohman (EP 3530670)

Novitsky, T.J. 2010

Notice of Opposition to EP 3530670

Register for EP 4291648 (excerpt)

Ding et al., 1995 from EP 3441466

Ding et al., 1995 from US 17650803

Ding et al., 1995 from US 18275777

Ding et al., 1995 from US 18953525

Ding et al., from Opposition to EP 3530670

Wang, et al., 2002 from EP 3441466

Wang, et al., 2002 from 17650803

Wang, et al., 2002 from 18275777

Wang, et al., 2002 from 18953525

Hossler, et al., 2009 from EP 3441466

Hossler, et al., 2009 from 17650803

Hossler, et al., 2009 from 18275777

Hossler, et al., 2009 from 18953525

U.S. Patent Application Publication 20230258647A1

Thorne et al., App Environ Microbiol 76(15) 4988-95 (2010)

WO2012118226A1

Ding, JL and Ho, B 187-208 (2010)

Hashiguchi, et al., 2008 from EP 3441466

Hashiguchi, et al., 2008 from 17650803

Tamura, H., EC Bacterio Virol Rsch (2016)

U.S. Patent No 6,391,570

Tokunaga, et al., 1991 from EP 3441466

Tokunaga, et al., 1991 from 17650803

Tokunaga, et al., 1991 from 18275777

Tokunaga, et al., 1991 from 18953525

File History for U.S. Patent No. 10,144,923 (excerpts)

File History for U.S. Patent No. 10,982,202 (excerpts)

Notice of Opposition to European Patent No. 3441466

D19, A Comparison of Limulus Factor C

Iwanaga, S., Curr. Op. Immunol. 5(1) 74-82 (1993)

Iwanaga, S. Thromb Haemost 70(01) 48-55 (1993)

Iwanaga, et al., J. Biochem 123 1-15 (1998)

Koshiba, et al., 2007 from EP 3441466

Koshiba, et al., 2007 from 17650803

Koshiba, et al., 2007 from 18275777

Koshiba, et al., 2007 from 18953525

Hashiguchi, et al., 2008 from 18275777

Hashiguchi, et al., 2008 from 18953525

U.S. Patent No. 10,473,663

Notice: Notice filing date accorded

Patent Owner's Mandatory Notices

Patent Owner's Power of Attorney

U.S. Patent No. 11,959,109

Prosecution History of U.S. Patent No. 11,959,109

Declaration of Siddhartha Jain, Ph.D., PMP ("Jain")

International Patent Publication No. WO 2018/074498 A1

Higdon et al., Proc Int Symp High Perform Distrib Comput. 2010: 499–502

Kobayashi et al., J Biol Chem. 2015 Jun 24; 290(31):19379–19386.

Japanese Priority Application No. JP2012-269840 (certified translation)

U.S. Patent No. 5,716,834

Muta et al., J Biol Chem. 1991 Apr 5; 266(10):6554-61.

Karen McClymont, Ph.D. Thesis, University of Glasgow, March 2017

U.S. Patent Application Publication No. 2021/0363564

Declaration of Dr. Mary K. Bolin

U.S. Patent Application Publication No. 2019/0241629

U.S. Patent Application Publication No. 2015/0307864

U.S. Patent Application No. 14/650,767, as filed June 9, 2015

Shi et al., Curr Drug Targets. 2007 Oct; 8(10): 1116–1125.

Transition Certification for U.S. Pat Appl No. 15/983,725, filed 5/31/2019

Tokunaga et al., J. Biochem. 1991 Jan;109(1):150-7.

Dwarakanath et al., Biotechnology Letters. 1997 April; 19(4):357-61.

Wang et al., Biotechnology Letters. 2001; 23:71-76.

Barrabes et al., Electrophoresis. 2010 Sep; 31(17):2903-12.

Palomares, Methods in Molecular Biology, Vol. 267, pp. 15-51 (2004).

Sekiguchi and Shuster, Biology and Conservation of Horseshoe Crabs, 2009.

Hossler et al., Glycobiology. 2009 Sep; 19(9):936-4.

File History of United States Application No. 16/399,386

ExpiCHO Expression System - USER GUIDE (Pub No. MAN0014337)

Curriculum Vitae of Dr. Siddhartha Jain, Ph.D., PMP

Power of Attorney

Petition for Post Grant Review